tiprankstipranks
Trending News
More News >
Ironwood Pharmaceuticals (IRWD)
:IRWD

Ironwood Pharma (IRWD) Stock Statistics & Valuation Metrics

Compare
311 Followers

Total Valuation

Ironwood Pharma has a market cap or net worth of $100.33M. The enterprise value is $1.67B.
Market Cap$100.33M
Enterprise Value$1.67B

Share Statistics

Ironwood Pharma has 161,819,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding161,819,850
Owned by Insiders13.05%
Owned by Institutions35.88%

Financial Efficiency

Ironwood Pharma’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 0.39%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.39%
Return on Capital Employed (ROCE)0.30
Revenue Per Employee1.39M
Profits Per Employee3.48K
Employee Count253
Asset Turnover1.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Ironwood Pharma is 800.84. Ironwood Pharma’s PEG ratio is -0.17.
PE Ratio800.84
PS Ratio0.00
PB Ratio2.93
Price to Fair Value-2.34
Price to FCF6.99
Price to Operating Cash Flow6.99
PEG Ratio-0.17

Income Statement

In the last 12 months, Ironwood Pharma had revenue of 351.41M and earned 880.00K in profits. Earnings per share was 0.01.
Revenue351.41M
Gross Profit351.41M
Operating Income93.12M
Pretax Income65.20M
Net Income880.00K
EBITDA100.24M
Earnings Per Share (EPS)0.01

Cash Flow

In the last 12 months, operating cash flow was 78.52M and capital expenditures -105.00K, giving a free cash flow of 78.41M billion.
Operating Cash Flow78.52M
Free Cash Flow78.41M
Free Cash Flow per Share0.48

Dividends & Yields

Ironwood Pharma pays an annual dividend of $2.285, resulting in a dividend yield of ―
Dividend Per Share$2.285
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.49
52-Week Price Change-89.12%
50-Day Moving Average0.77
200-Day Moving Average2.76
Relative Strength Index (RSI)44.49
Average Volume (3m)3.01M

Important Dates

Ironwood Pharma upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateApr 02, 2019

Financial Position

Ironwood Pharma as a current ratio of 4.69, with Debt / Equity ratio of 63.75%
Current Ratio4.69
Quick Ratio4.69
Debt to Market Cap0.83
Net Debt to EBITDA5.10
Interest Coverage Ratio2.82

Taxes

In the past 12 months, Ironwood Pharma has paid 64.32M in taxes.
Income Tax64.32M
Effective Tax Rate0.99

Enterprise Valuation

Ironwood Pharma EV to EBITDA ratio is 12.13, with an EV/FCF ratio of 11.76.
EV to Sales3.46
EV to EBITDA12.13
EV to Free Cash Flow11.76
EV to Operating Cash Flow11.74

Balance Sheet

Ironwood Pharma has $108.48M in cash and marketable securities with $599.08M in debt, giving a net cash position of $490.60M billion.
Cash & Marketable Securities$108.48M
Total Debt$599.08M
Net Cash$490.60M
Net Cash Per Share$3.03
Tangible Book Value Per Share-$1.91

Margins

Gross margin is 99.65%, with operating margin of 26.50%, and net profit margin of 0.25%.
Gross Margin99.65%
Operating Margin26.50%
Pretax Margin18.55%
Net Profit Margin0.25%
EBITDA Margin28.53%
EBIT Margin27.95%

Analyst Forecast

The average price target for Ironwood Pharma is $0.85, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$0.85
Price Target Upside37.10% Upside
Analyst ConsensusHold
Analyst Count6
Revenue Growth Forecast-23.18%
EPS Growth Forecast97.12%

Scores

Smart Score5
AI Score45
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis